Skip to Main Content

Author Details

Akinyemi I Ojesina
University of Alabama at Birmingham
2002
48
25
PMIDPaper TitleJournal TitlePublished Year
37279409Evaluating Nurses' Time to Response by Severity and Cancer Stage in a Remote Symptom Monitoring Program for Patients With Breast Cancer.JCO Clin Cancer Inform2023
37410084Variations in Genes Encoding Human Papillomavirus Binding Receptors and Susceptibility to Cervical Precancer.Cancer Epidemiol Biomarkers Prev2023
37279409Evaluating Nurses' Time to Response by Severity and Cancer Stage in a Remote Symptom Monitoring Program for Patients With Breast Cancer.JCO Clin Cancer Inform2023
35348413Partnership status and retention in care among cisgender heterosexual newly diagnosed people with HIV: a cohort study.AIDS Care2023
35348413Partnership status and retention in care among cisgender heterosexual newly diagnosed people with HIV: a cohort study.AIDS Care2023
37410084Variations in Genes Encoding Human Papillomavirus Binding Receptors and Susceptibility to Cervical Precancer.Cancer Epidemiol Biomarkers Prev2023
34486556Treatment-related Correlates of Growth in Children With Sickle Cell Disease in the DISPLACE Cohort.J Pediatr Hematol Oncol2022
35379913Genome-wide variants and polygenic risk scores for cognitive impairment following blood or marrow transplantation.Bone Marrow Transplant2022
34486556Treatment-related Correlates of Growth in Children With Sickle Cell Disease in the DISPLACE Cohort.J Pediatr Hematol Oncol2022
35085052Partnership status and time to viral suppression and sustained viral suppression among newly diagnosed heterosexual people with HIV.Int J STD AIDS2022
35379913Genome-wide variants and polygenic risk scores for cognitive impairment following blood or marrow transplantation.Bone Marrow Transplant2022
35085052Partnership status and time to viral suppression and sustained viral suppression among newly diagnosed heterosexual people with HIV.Int J STD AIDS2022
34189853Immunophenotype-associated gene signature in ductal breast tumors varies by receptor subtype, but the expression of individual signature genes remains consistent.Cancer Med2021
33664239Inhibiting β-catenin disables nucleolar functions in triple-negative breast cancer.Cell Death Dis2021
34203201Dissection of <i>PIK3CA</i> Aberration for Cervical Adenocarcinoma Outcomes.Cancers (Basel)2021
33723390A 10-gene prognostic signature points to LIMCH1 and HLA-DQB1 as important players in aggressive cervical cancer disease.Br J Cancer2021
34189853Immunophenotype-associated gene signature in ductal breast tumors varies by receptor subtype, but the expression of individual signature genes remains consistent.Cancer Med2021
34572780Genomic Characterization and Therapeutic Targeting of HPV Undetected Cervical Carcinomas.Cancers (Basel)2021
34620846Genomic alterations associated with mutational signatures, DNA damage repair and chromatin remodeling pathways in cervical carcinoma.NPJ Genom Med2021
33664239Inhibiting β-catenin disables nucleolar functions in triple-negative breast cancer.Cell Death Dis2021
33723390A 10-gene prognostic signature points to LIMCH1 and HLA-DQB1 as important players in aggressive cervical cancer disease.Br J Cancer2021
34572780Genomic Characterization and Therapeutic Targeting of HPV Undetected Cervical Carcinomas.Cancers (Basel)2021
34620846Genomic alterations associated with mutational signatures, DNA damage repair and chromatin remodeling pathways in cervical carcinoma.NPJ Genom Med2021
34203201Dissection of <i>PIK3CA</i> Aberration for Cervical Adenocarcinoma Outcomes.Cancers (Basel)2021
32868873HPV-EM: an accurate HPV detection and genotyping EM algorithm.Sci Rep2020
32868873HPV-EM: an accurate HPV detection and genotyping EM algorithm.Sci Rep2020
32747824Analysis of Ugandan cervical carcinomas identifies human papillomavirus clade-specific epigenome and transcriptome landscapes.Nat Genet2020
33391980Race/ethnicity, sex and insurance disparities in colorectal cancer screening among individuals with and without cardiovascular disease.Prev Med Rep2020
33391980Race/ethnicity, sex and insurance disparities in colorectal cancer screening among individuals with and without cardiovascular disease.Prev Med Rep2020
32747824Analysis of Ugandan cervical carcinomas identifies human papillomavirus clade-specific epigenome and transcriptome landscapes.Nat Genet2020
31433971The Immune Landscape of Cancer.Immunity2019
31637877Gain of function in somatic TP53 mutations is associated with immune-rich breast tumors and changes in tumor-associated macrophages.Mol Genet Genomic Med2019
31433971The Immune Landscape of Cancer.Immunity2019
31637877Gain of function in somatic TP53 mutations is associated with immune-rich breast tumors and changes in tumor-associated macrophages.Mol Genet Genomic Med2019
29622464A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers.Cancer Cell2018
29982281GATK PathSeq: a customizable computational tool for the discovery and identification of microbial sequences in libraries from eukaryotic hosts.Bioinformatics2018
30305637Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia.Nat Commun2018
30096301Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.Cell2018
29622466Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas.Cancer Cell2018
29622464A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers.Cancer Cell2018
29617660Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas.Cell Rep2018
30096301Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.Cell2018
29982281GATK PathSeq: a customizable computational tool for the discovery and identification of microbial sequences in libraries from eukaryotic hosts.Bioinformatics2018
30305637Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia.Nat Commun2018
29617660Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas.Cell Rep2018
29622466Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas.Cancer Cell2018
28049703Pathway-Structured Predictive Model for Cancer Survival Prediction: A Two-Stage Approach.Genetics2017
28599900Clinicopathologic and molecular markers in cervical carcinoma: a prospective cohort study.Am J Obstet Gynecol2017
28988769Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.Cell2017
28658632Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles.Cell Rep2017
  • 1 - 50 of 96

Recommended Authors

Washington University in St. Louis School of Medicine
Career Start Year 2015
Number of shared co-authors 7
Faculdade de Medicina
Career Start Year 2013
Number of shared co-authors 0
Illumina Inc.
Career Start Year 2011
Number of shared co-authors 3
Mayo Clinic
Career Start Year 2007
Number of shared co-authors 2
Columbia University Vagelos College of Physicians and Surgeons
Career Start Year 2006
Number of shared co-authors 13
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 12
Manchester Cancer Research Centre, University of Manchester
Career Start Year 2006
Number of shared co-authors 16
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 4
National Cancer Institute
Career Start Year 2005
Number of shared co-authors 14
Universite Cote d'Azur, CNRS UMR5
Career Start Year 2004
Number of shared co-authors 0
University of Dhaka
Career Start Year 2004
Number of shared co-authors 0
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 1
Washington University
Career Start Year 2003
Number of shared co-authors 15
University of California
Career Start Year 2003
Number of shared co-authors 3
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 1
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 31
Queen's University
Career Start Year 2002
Number of shared co-authors 3
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 6
National Cancer Institute, National Institutes of Health, Inc.
Career Start Year 2001
Number of shared co-authors 13
The Scripps Research Institute
Career Start Year 1999
Number of shared co-authors 4
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 7
Institute for Human Genetics, University of California san francisco
Career Start Year 1998
Number of shared co-authors 67
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 68
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 9
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 5
Princess Margaret Cancer Centre
Career Start Year 1991
Number of shared co-authors 4
Stanford University School of Medicine
Career Start Year 1991
Number of shared co-authors 5
Dartmouth Health and the Dartmouth Cancer Center, USA Geisel School of Medicine
Career Start Year 1990
Number of shared co-authors 1
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 5
The Ohio State University
Career Start Year 1988
Number of shared co-authors 43

Collaborators

Broad Institute
Co-authored papers 21
Broad Institute
Co-authored papers 12
Dana-Farber Cancer Institute
Co-authored papers 9
Fred Hutchinson Cancer Center
Co-authored papers 7
The University of Texas MD Anderson Cancer Center
Co-authored papers 7
Co-authored papers 7
Broad Institute of MIT and Harvard
Co-authored papers 7
Present address: Dxige Research Inc.
Co-authored papers 6
St Vincent's Hospital Melbourne
Co-authored papers 6
Van Andel Institute
Co-authored papers 6
Broad Institute of the Massachusetts Institute of Technology and Harvard
Co-authored papers 6
Co-authored papers 5
Co-authored papers 5
The University of Texas MD Anderson Cancer Center
Co-authored papers 5
Co-authored papers 5
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Co-authored papers 5
Co-authored papers 5
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
Cumming School of Medicine, University of Calgary
Co-authored papers 4
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 4
Co-authored papers 3
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Van Andel Institute
Co-authored papers 3
Baylor College of Medicine
Co-authored papers 3
Co-authored papers 3
University of California at Santa Cruz
Co-authored papers 3
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Broad Institute of MIT and Harvard
Co-authored papers 2